Scott Nelson, co-founder and CEO of FastWave Medical More than a third of insured American adults, and three in four without coverage, skipped or delayed healthcare they needed last year because they couldn’t afford it, according to a 2025 KFF survey. And cost is only one barrier. Patients who can pay still run into a specialist […]
Reimbursement
Edwards Lifesciences, Medtronic score CMS win for TAVR
Edwards Lifesciences (NYSE: EW) and Medtronic (NYSE: MDT) are among the medtech companies praising CMS’s decision to expand Medicare coverage for TAVR to people with asymptomatic severe aortic stenosis. The finalized national coverage decision, published yesterday evening, also removes the evidence development (CED) requirement for symptomatic cases. In addition, CMS plans to review the evidence […]
CVRx earns new Medicare Advantage coverage policy for Barostim
CVRx (Nasdaq: CVRX) earned a new Medicare Advantage coverage policy from Devoted Health for its Barostim therapy, the company announced today. Barostim is an implantable pulse generator that electrically stimulates baroreceptors in the carotid artery to rebalance the nervous system and improve heart failure symptoms. The new policy covers the implant for patients with heart […]
Tandem Diabetes Care seeing early benefits of new pay-as-you-go model
Tandem Diabetes Care (Nasdaq: TNDM) says U.S. sales of its insulin pumps were boosted by a scaled pay-as-you-go reimbursement model that’s been rolling out this year. According to the San Diego–based company’s second-quarter report, released after market close yesterday, the alternative reimbursement structure, available through patients’ pharmacy benefits rather than medical benefits, eliminates upfront pump […]
Lungpacer picks up reimbursement win for AeroPace
Lungpacer Medical today announced new Category III Current Procedural Terminology (CPT) codes granted for its AeroPace system. The new codes, granted by the American Medical Association (AMA), cover temporary transvenous diaphragm neurostimulation with AeroPace. These temporary codes, which went into effect on July 1, 2026, enable the standardized reporting of procedures and support the development […]
Novocure has reimbursement win for Optune Lua in Japan
Novocure (Nasdaq:NVCR) announced today that Japan’s Ministry of Health, Labour and Welfare (MHLW) approved reimbursement for its Optune Lua system. Optune Lua a wearable, portable medical device, produces alternating electric fields called tumor-treating fields (TTFields). Delivered through non-invasive, wearable arrays, TTFields exert physical forces on the electrically charged components of dividing cancer cells. Alternating electrical […]
Recor Medical also secures renal denervation reimbursement in Japan
Recor Medical is gaining reimbursement in Japan’s healthcare system for its Paradise renal denervation for treating hypertension, enabling it to better compete with Medtronic’s rival Symplicity Spyral system. Paradise is included in the same Central Social Insurance Medical Council General schedule as Symplicity. The council advises Japan’s Ministry of Health, Labour and Welfare (MHLW). Medtronic […]
Medtronic renal denervation has a reimbursement win in Japan
Medtronic continues to expand the growth opportunities for its hypertension-treating Symplicity Spyral renal denervation system. The Minnesota-run medtech giant announced today that Japan’s Ministry of Health, Labour and Welfare (MHLW) has approved reimbursement for the system. “This decision enables broader access to a therapy that has been shown to provide sustained reductions in blood pressure […]
CMS adds reimbursement for cardiac ablation in ASCs
The Centers for Medicare and Medicaid Services (CMS) has provided a major reimbursement update for cardiac ablation technologies. In its 2026 Hospital Outpatient Prospective Payment System (OPPS) and Ambulatory Surgical Center (ASC) Payment System final rule, CMS added AFib-treating cardiac catheter ablation procedures to its ASC-covered procedures list. This follows advocacy efforts from a range […]
HistoSonics earns first major reimbursement win for non-invasive histotripsy
HistoSonics announced today that Blue Cross Blue Shield of Michigan (BCBSM) and the Blue Care Network created a new medical policy for histotripsy of the liver. The policy covers non-thermal histotripsy using the Minneapolis-based company’s Edison system. It marks the company’s first major insurance coverage for the non-invasive treatment for primary and metastatic liver tumors. […]
CMS proposes approval of additional payment for Sequana Alfapump
Sequana Medical announced today that CMS recommended that its Alfapump system become eligible for a new incremental payment. Alfapump treats these fluid overload conditions that arise due to liver cirrhosis and malignant ascites. The fully implantable, wirelessly charged device continuously collects ascites as it forms in the abdominal cavity. It then moves into the bladder, […]
